| Product Code: ETC11643054 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Cinv Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Cinv Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Cinv Market - Industry Life Cycle |
3.4 Ireland Cinv Market - Porter's Five Forces |
3.5 Ireland Cinv Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ireland Cinv Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.7 Ireland Cinv Market Revenues & Volume Share, By Emetogenic Risk Level, 2021 & 2031F |
3.8 Ireland Cinv Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Cinv Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of cannabis for medical purposes in Ireland |
4.2.2 Growing research and development activities related to cannabis-based therapies |
4.2.3 Favorable regulatory environment and potential legalization of medical cannabis in Ireland |
4.3 Market Restraints |
4.3.1 Stringent regulations and licensing requirements for cannabis products in Ireland |
4.3.2 Limited availability of medical cannabis products and dispensaries |
4.3.3 Stigma and societal perceptions surrounding the use of cannabis for medical purposes |
5 Ireland Cinv Market Trends |
6 Ireland Cinv Market, By Types |
6.1 Ireland Cinv Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ireland Cinv Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Ireland Cinv Market Revenues & Volume, By 5HT3 Receptor Antagonist, 2021 - 2031F |
6.1.4 Ireland Cinv Market Revenues & Volume, By Neurokinin1 (NK1) Receptor Antagonists, 2021 - 2031F |
6.1.5 Ireland Cinv Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.1.6 Ireland Cinv Market Revenues & Volume, By Cannabinoids, 2021 - 2031F |
6.1.7 Ireland Cinv Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Ireland Cinv Market, By Formulation |
6.2.1 Overview and Analysis |
6.2.2 Ireland Cinv Market Revenues & Volume, By Injectables, 2021 - 2031F |
6.2.3 Ireland Cinv Market Revenues & Volume, By Oral Tablets, 2021 - 2031F |
6.2.4 Ireland Cinv Market Revenues & Volume, By Transdermal Patches, 2021 - 2031F |
6.3 Ireland Cinv Market, By Emetogenic Risk Level |
6.3.1 Overview and Analysis |
6.3.2 Ireland Cinv Market Revenues & Volume, By Highly Emetogenic Chemotherapy (HEC), 2021 - 2031F |
6.3.3 Ireland Cinv Market Revenues & Volume, By Moderately Emetogenic Chemotherapy (MEC), 2021 - 2031F |
6.3.4 Ireland Cinv Market Revenues & Volume, By Low Emetogenic Chemotherapy (LEC), 2021 - 2031F |
6.4 Ireland Cinv Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Cinv Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Ireland Cinv Market Revenues & Volume, By Cancer Research Institutes, 2021 - 2031F |
6.4.4 Ireland Cinv Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.5 Ireland Cinv Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.6 Ireland Cinv Market Revenues & Volume, By Drug Stores, 2021 - 2031F |
7 Ireland Cinv Market Import-Export Trade Statistics |
7.1 Ireland Cinv Market Export to Major Countries |
7.2 Ireland Cinv Market Imports from Major Countries |
8 Ireland Cinv Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on cannabis-based therapies in Ireland |
8.2 Patient enrollment in medical cannabis programs and prescriptions issued |
8.3 Investments in the Irish cannabis industry for infrastructure and technology advancements |
9 Ireland Cinv Market - Opportunity Assessment |
9.1 Ireland Cinv Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ireland Cinv Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.3 Ireland Cinv Market Opportunity Assessment, By Emetogenic Risk Level, 2021 & 2031F |
9.4 Ireland Cinv Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Cinv Market - Competitive Landscape |
10.1 Ireland Cinv Market Revenue Share, By Companies, 2024 |
10.2 Ireland Cinv Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here